Leaf Pharma

Alectinib Capsules150 mg

PRODUCT INTRODUCTION
ALECENSA 150MG CAPSULE IS USED IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER. IT BLOCKS CERTAIN RECEPTORS FOUND ON THE CANCER CELLS THAT CAUSE THE CANCER CELLS TO GROW AND MULTIPLY VERY FAST. THIS WAY IT HELPS TO SLOW OR STOP THE TUMOR GROWTH.
ALECENSA 150MG CAPSULE SHOULD BE TAKEN IN A DOSE AS RECOMMENDED BY THE DOCTOR. YOU SHOULD CONTINUE TO TAKE IT AS LONG AS YOUR DOCTOR ADVISES FOR IT. THE DURATION OF TREATMENT VARIES ACCORDING TO YOUR NEED AND RESPONSE TO TREATMENT. YOUR DOCTOR MAY ADVICE FOR REGULAR MONITORING OF LIVER AND KIDNEY FUNCTION WHILE YOUR TAKING THIS MEDICINE.
WOMEN WHO ARE UNDERGOING TREATMENT SHOULD USE EFFECTIVE CONTRACEPTION METHOD AND AVOID PREGNANCY. THIS MEDICINE MAY MAKE YOUR SKIN MORE SENSITIVE TO SUN, SO IT IS BETTER TO USE SUNSCREEN AND PROTECTIVE CLOTHING WHEN OUTDOORS. REMEMBER TO INFORM DOCTOR IF YOU DEVELOP BREATHING DIFFICULTIES, STOMACH PAIN, OR YELLOWING OF SKIN AFTER TAKING ALECENSA 150MG CAPSULE.

USES OF ALECENSA STRIP
• NON-SMALL CELL LUNG CANCER

SIDE EFFECTS OF ALECENSA STRIP
MOST SIDE EFFECTS DO NOT REQUIRE ANY MEDICAL ATTENTION AND DISAPPEAR AS YOUR BODY ADJUSTS TO THE MEDICINE. CONSULT YOUR DOCTOR IF THEY PERSIST OR IF YOU’RE WORRIED ABOUT THEM

COMMON SIDE EFFECTS OF ALECENSA
• TIREDNESS
• CONSTIPATION
• PERIPHERAL EDEMA
• MUSCLE PAIN
• MUSCLE WEAKNESS
• DECREASED RED BLOOD CELL COUNT

HOW TO USE ALECENSA STRIP
TAKE THIS MEDICINE IN THE DOSE AND DURATION AS ADVISED BY YOUR DOCTOR. CHECK THE LABEL BEFORE USE. ALECENSA 150MG CAPSULE IS TO BE TAKEN WITH FOOD.

HOW ALECENSA STRIP WORKS
ALECENSA 150MG CAPSULE IS AN ANTICANCER MEDICATION. IT WORKS BY BLOCKING CERTAIN RECEPTORS FOUND ON THE CANCER CELLS. THESE RECEPTORS CAUSE THE CANCER CELLS TO GROW AND MULTIPLY VERY FAST. HENCE, BLOCKING THEM HELPS TO SLOW OR STOP TUMOR GROWTH.

SAFETY ADVICE

ALCOHOL
ALECENSA 150MG CAPSULE MAY CAUSE EXCESSIVE DROWSINESS WITH ALCOHOL.

PREGNANCY
ALECENSA 150MG CAPSULE IS HIGHLY UNSAFE TO USE DURING PREGNANCY. SEEK YOUR DOCTOR'S ADVICE AS STUDIES ON PREGNANT WOMEN AND ANIMALS HAVE SHOWN SIGNIFICANT HARMFUL EFFECTS TO THE DEVELOPING BABY.

BREAST FEEDING
ALECENSA 150MG CAPSULE IS PROBABLY UNSAFE TO USE DURING BREASTFEEDING. LIMITED HUMAN DATA SUGGESTS THAT THE DRUG MAY PASS INTO THE BREASTMILK AND HARM THE BABY.

DRIVING
ALECENSA 150MG CAPSULE MAY CAUSE DIZZINESS OR WEAKNESS DUE TO LOW BLOOD PRESSURE. DO NOT DRIVE IF THESE SYMPTOMS OCCUR.

KIDNEY
THERE IS NO DATA AVAILABLE. PLEASE CONSULT DOCTOR BEFORE CONSUMING THE DRUG.

LIVER
THERE IS NO DATA AVAILABLE. PLEASE CONSULT DOCTOR BEFORE CONSUMING THE DRUG.

Calquence Acalabrutinib Tablet 

Product IntroductionCalquence 100mg Capsule is used in the treatment of blood cancer. It is given to patients aged more than 18 years who have received at least one prior treatment for their cancer. It is unknown if this drug is safe and effective in children.
Calquence 100mg Capsule is taken orally, preferably with food or between meals. It should be used in the dose and duration prescribed by your doctor. It is advised to take this medicine at a fixed time and for as long as the doctor prescribes to avoid missing a dose. It may take several weeks or months for you to see or feel the benefits.
The most common side effects of Calquence 100mg Capsule include anemia, neutropenia, upper respiratory tract infection, thrombocytopenia, headache, diarrhea, and musculoskeletal pain. If these bother you or appear serious, let your doctor know as they might suggest ways of reducing or preventing these side effects.

USES OF CALQUENCE CAPSULE• Treatment of Blood cancer• Pancreatic cancer• Small cell lung cancer• Liver cancer• Kidney cancer• Thyroid cancer• Blood cancer (Chronic myeloid leukaemia)• Gastrointestinal stromal tumour• Cancer of colon and rectum• Non-small cell lung cancer• Soft tissue sarcoma• Chronic idiopathic myelofibrosis• Breast cancer

BENEFITS OF CALQUENCE CAPSULEIn Treatment of Blood cancerBlood cancer, also called leukemia, is a cancer of the blood-forming tissues that decreases the body's ability to fight infection. Calquence 100mg Capsule kills or stops the growth and prevents the multiplication of cancer cells. It is a potent and very toxic medicine, and one should discuss the risks and benefits with the doctor before taking this drug. Avoid drinking alcohol while taking this medicine and also inform the doctor if you have any persistent side effects.

SIDE EFFECTS OF CALQUENCE CAPSULEMost side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Calquence• Anemia (low number of red blood cells)• Decreased white blood cell count (neutrophils)• Upper respiratory tract infection• Low blood platelets• Headache• Diarrhea• Musculoskeletal (bone, muscle or joint) pain
HOW TO USE CALQUENCE CAPSULE• Take this medicine in the dose and duration as advised by your doctor. Calquence 100mg       Capsule may be taken with or without food, but it is better to take it at a fixed time.
HOW CALQUENCE CAPSULE WORKSCalquence 100mg Capsule works by blocking the action of an abnormal protein that promotes the multiplication of cancer cells. This helps stop the spread of cancer cells.
SAFETY ADVICE AlcoholIt is not known whether it is safe to consume alcohol with Calquence 100mg Capsule. Please consult your doctor. PregnancyCalquence 100mg Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor. Breast feedingCalquence 100mg Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. DrivingCalquence 100mg Capsule does not usually affect your ability to drive. KidneyCalquence 100mg Capsule is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Calquence 100mg Capsule may not be needed in these patients. Please consult your doctor.

Celbopag Eltrombopag 25mg Tablet
Product IntroductionCelbopag 25 Tablet is used to treat low platelet count due to chronic immune (idiopathic) thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection. It is also used to treat severe aplastic anemia.
Celbopag 25 Tablet is a thrombopoietin agonist. It works by stimulating the formation of new platelets in the blood. The function of platelets is to help reduce bleeding.
Take it in the exact dose and duration as advised by the doctor. You may take it on an empty stomach. This medicine is to be swallowed as a whole. Do not chew, crush or break it. Inform your doctor if you have any known allergies to this medication.
The common side effects include nausea, vomiting, diarrhea, upper respiratory tract infection, and urinary tract infection. Let your doctor know if any of these side effects bother you. They may be able able to suggest ways to reduce or treat the symptoms.
Before you take this medicine, inform your doctor if you have any preexisting medical conditions. Let your doctor also know about all the other medicines you are taking. Dose adjustments may be required in patients with liver diseases, inform your doctor.

Uses of Celbopag TabletChronic idiopathic thrombocytopeniaTreatment of Severe Aplastic AnemiaLow platelet count due to ITP or HCV infection

Benefits of Celbopag TabletIn Treatment of Severe Aplastic AnemiaCelbopag 25 Tablet is also used in combination with other medications to treat aplastic anemia, a condition in which the body does not make enough new blood cells, in adults and children 2 years of age and above. Take it as advised by the doctor to get the most benefits.

Side effects of Celbopag TabletMost side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about themCommon side effects of Celbopag  NauseaDiarrheaVomitingIncreased liver enzymesMuscle painUrinary tract infection

How to use Celbopag TabletTake this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Celbopag 25 Tablet is to be taken on an empty stomach.

How Celbopag Tablet worksCelbopag 25 Tablet is a thrombopoietin agonist. It works by stimulating the formation of new platelets in the blood. Platelets help to reduce or prevent bleeding.

Safety adviceAlcoholIt is not known whether it is safe to consume alcohol with Celbopag 25 Tablet. Please consult your doctor.
PregnancyCelbopag 25 Tablet is not recommended during pregnancy as there is positive evidence of fetal risk based on animal studies. However, it may still be prescribed by a doctor in situations where the benefits outweigh the risks.
Breast feedingCelbopag 25 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
DrivingIt is not known whether Celbopag 25 Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react. Please consult your doctor.
KidneyThere is limited data available on the use of Celbopag 25 Tablet in patients with kidney disease. Please consult your doctor.
LiverThere is limited data available on the use of Celbopag 25 Tablet in patients with liver disease.

LuciNira 100mg is a branded formulation of Niraparib, an oral anticancer drug belonging to the class of poly (ADP-ribose) polymerase (PARP) inhibitors. It is primarily used in the treatment of certain types of ovarian cancers and other gynecologic malignancies. Manufactured for targeted cancer therapy, LuciNira offers new hope to patients with recurrent or resistant forms of cancer, particularly those who have responded to previous platinum-based chemotherapy.

What is LuciNira 100mg (Niraparib)?

Niraparib, a PARP inhibitor intended to obstruct cancer cell repair processes, is present in LuciNira 100mg. PARP enzymes are critical in repairing DNA damage in cells. Niraparib targets cancer cells with deficient DNA repair pathways—such as those in BRCA-mutated tumors—making it harder for the tumor to survive. LuciNira is used as maintenance therapy and is prescribed after a positive response to chemotherapy.

Mechanism of Action

Niraparib inhibits the PARP-1 and PARP-2 enzymes, which play essential roles in the repair of single-strand DNA breaks through the base excision repair pathway. Inhibition of PARP leads to the accumulation of DNA damage and eventually causes cell death, especially in tumor cells that already have defective DNA repair mechanisms due to BRCA1/BRCA2 mutations or homologous recombination deficiency (HRD).

This synthetic lethality mechanism spares normal cells while targeting malignant ones, reducing the risk of toxicity typically seen in traditional chemotherapy.

How to Use / Indications

LuciNira 100mg is approved for the following indications:

• Adult patients with primary peritoneal, fallopian tube, or advanced epithelial ovarian cancer who are responding fully or partially to first-line platinum-based chemotherapy are treated with maintenance therapy.

• Maintenance treatment in patients with recurrent ovarian cancer responding to platinum-based chemotherapy, regardless of BRCA mutation status.

• treatment of patients with HRD-positive tumors who have had three or more previous chemotherapy treatments for advanced ovarian cancer.

How to Take / Dosage

Standard Dosage:

• The typical starting dose of LuciNira is 300 mg once daily, which equals 3 capsules of 100mg taken orally.

• The dose can be adjusted based on body weight and platelet count:

• 200 mg daily for patients weighing <77 kg or with platelet count <150,000/μL.

Administration Guidelines:

• Take at the same time each day, preferably in the evening.

• It can be taken with or without food.

• Swallow the capsule whole; do not chew, crush, or open.

• If a dose is missed, it can be taken within 12 hours; if more than 12 hours have passed, skip the dose and resume the next day.

Side EffectsCommon Side Effects:

• Nausea and vomiting

• Fatigue

• Constipation

• Loss of appetite

• Insomnia

• Dizziness

• Headache

Serious Side Effects:

• Thrombocytopenia

• Anemia

• Neutropenia

• Hypertension

• Acute myeloid leukemia

Storage

• Store at room temperature (15°C–30°C).

• Keep the capsules in the original container to protect from moisture.

• Keep out of reach of children.

• Do not use beyond the expiry date printed on the packaging.

Benefits

• Targeted Therapy

• Oral Convenience

• Extended Remission

• Effective in HRD and BRCA-mutated cancers

Erivedge Vismodegib 150mg Capsules
Product Introduction Erivedge Vismodegib 150 mg Capsules is a prescription anticancer medication used for the treatment of specific forms of basal cell carcinoma, which is the most common type of skin cancer. It contains Vismodegib as its active ingredient and belongs to a specialized class of medicines known as Hedgehog pathway inhibitors. This targeted therapy is intended for patients whose cancer is advanced, recurrent, or has spread to other parts of the body and cannot be adequately treated with surgery or radiation therapy.
Basal cell carcinoma develops due to abnormal activation of the Hedgehog signaling pathway, a biological pathway that regulates normal cell growth and development. In many BCC cases, this pathway becomes overactive, leading to uncontrolled growth of cancer cells. Vismodegib works by selectively blocking this pathway, thereby stopping the signals that allow cancer cells to grow and survive. As a result, Erivedge helps slow down disease progression and may reduce tumor size in responsive patients.
Vismodegib is administered orally as a capsule taken once daily, offering a convenient treatment option for long-term management outside the hospital setting. However, due to its potent effects and potential for serious adverse reactions—particularly severe birth defects—its use requires strict medical supervision and adherence to safety guidelines. Both male and female patients must follow effective contraception measures during treatment and for an extended period after stopping the medicine.

Uses of Vismodegib CapsulesMetastatic basal cell carcinomaLocally advanced basal cell carcinoma that cannot be treated with surgery or radiationRecurrent basal cell carcinoma after previous treatments

Benefits of Vismodegib CapsulesTargets the underlying cause of basal cell carcinomaHelps slow down or stop the growth of cancer cellsMay reduce tumor size and control disease progression


Side effects of Vismodegib CapsulesMuscle spasmsHair lossFatigueWeight lossLoss of appetiteNausea and vomitinChange in taste sensation

How to use Vismodegib CapsulesTake the capsule exactly as prescribed by your doctorUsually taken once dailyCan be taken with or without foodSwallow the capsule whole with waterDo not open, crush, or chew the capsuleIf a dose is missed, skip it—do not double the next dose

How Vismodegib Capsules works :Stops abnormal cancer cell signalingPrevents cancer cells from growing and multiplyingHelps control tumor progression

Safety advice Alcohol Alcohol may worsen side effects such as nausea, fatigue, or liver-related issues. Consult your doctor before consuming alcohol.
Pregnancy Erivedge can cause severe birth defects or fetal death. It must not be used during pregnancy. Both men and women must use effective contraception during treatment and for a specified period after stopping the medicine.
Breast feeding Breastfeeding should be avoided during treatment and for at least 24 months after the last dose, as the drug may pass into breast milk and harm the baby.
Driving Fatigue or muscle spasms may occur. Avoid driving if you feel unwell or tired.
Kidney No specific dose adjustment is usually required, but caution is advised in patients with severe kidney impairment.
LiverAlthough dose adjustment is generally not required, liver function should be monitored during treatment, especially in patients with existing liver disease.

Per-jeta 420mg, Pertuzumab Injection

Product introduction
Breast cancer is treated with perjeta injections. It is a member of the class of medications known as monoclonal antibodies.
Under a doctor's supervision, Perjeta Injection is administered as an injection into veins. The recommended dosage and frequency of administration will be determined by your physician. This will vary depending on the condition for which you are receiving treatment. You should take it exactly as prescribed by your physician. Very dangerous negative effects can result from taking it incorrectly or in excess. You might not notice or feel the advantages for a few weeks or months, but don't stop taking it until your doctor instructs you to.

This medication frequently causes fatigue, nausea, diarrhea, and hair loss. This medication may cause your blood's white blood cell count to drop, making you more vulnerable to infections. Your heart, liver, kidney, and blood cells must all be checked on a regular basis.

Tell your healthcare provider about all the medications you take because many other medications can either impact or be affected by this medication. It is not advised to use this medication when nursing or pregnant. It is crucial for both men and women to take adequate contraception during therapy in order to prevent conception.

Uses of Perjeta InjectionBreast cancer

Side effects of Perjeta InjectionHair lossFeeling sickRashStomach inflammationDecreased blood cells (red cells, white cells, and platelets)Muscle painCoughHeartburnBreathlessnessDizzinessFatigueDiarrhea

How to use Perjeta Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer

How Perjeta Injection worksPerjeta Injection is a monoclonal antibody designed to recognize and attach to specific proteins on the surface of cancer cells. Perjeta Injection gets attached to human epidermal growth factor receptor 2( HER2) and may kill or stop the growth of cancer cells.


Safety advice
AlcoholIt is not known whether it is safe to consume alcohol with Perjeta Injection. Please consult your doctor.
PregnancyPerjeta Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feedingPerjeta Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
DrivingIt is not known whether Perjeta Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
KidneyPerjeta Injection is safe to use in patients with kidney disease. No dose adjustment of Perjeta Injection is recommended.
LiverThere is limited information available on the use of Perjeta Injection in patients with liver disease. Please consult your doctor.

Rozlytrek 200 mg Hard Capsules Entrectinib

Product Introduction
Rozlytrek (entrectinib) is a kinase inhibitor indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are ROS1-positive; and adult and pediatric patients 12 years of age and older with solid tumors that have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion without a known acquired resistance mutation, are metastatic or where surgical resection is likely to result in severe morbidity, and have progressed following treatment or have no satisfactory alternative therapy.

Side Effects Of Rozlytrek
Rozlytrek may cause serious side effects including:

· hives
· difficulty breathing
· swelling of your face, lips, tongue, or throat
· bone pain
· problems moving
· fast or pounding heartbeats
· fluttering in your chest
· shortness of breath
· sudden dizziness
· nausea
· vomiting
· loss of appetite
· right side upper stomach pain
· swelling in your lower legs
· rapid weight gain
· cough
·  wheezing
· trouble breathing while laying down
· confusion
· hallucinations
· problems with memory or concentration
· dizziness
· mood changes
· trouble sleeping
· blurred vision
· double vision
· increased sensitivity to light
· seeing flashes of light
· "floaters" in your vision

Common Side Effects Of Rozlytrek Include:

· fatigue
· constipation
· changes in taste
· fluid retention/swelling
· dizziness
· diarrhea
· nausea
· impaired sense of touch
· shortness of breath
· muscle pain
· cognitive impairment
· weight gain
· cough
· vomiting
· fever
· joint pain
· vision disorders

Dosage For Rozlytrek
The recommended dosage of Rozlytrek for ROS1-Positive non-small cell lung cancer is 600 mg orally once daily. The recommended adult dosage of Rozlytrek for NTRK gene fusion-positive solid tumors is 600 mg orally once daily. The recommended dosage of Rozlytrek is based on body surface area.

What Drugs, Substances, Or Supplements Interact With Rozlytrek?
Rozlytrek may interact with grapefruit and grapefruit products, strong or moderate CYP3A inhibitors or inducers, and medications that prolong the QT/QTc interval. Tell your doctor all medications and supplements you use.

Rozlytrek During Pregnancy And Breastfeeding

Rozlytrek is not recommended for use during pregnancy; it may harm a fetus. Females of reproductive potential are advised to use effective contraception during treatment with Rozlytrek and for 5 weeks following the final dose. Males with female partners of reproductive potential are advised to use effective contraception during treatment with Rozlytrek and for 3 months after the final dose. Because of the potential adverse reactions in breastfed children, breastfeeding is not recommended during treatment with Rozlytrek and for 7 days after the final dose.

Additional Information

Our Rozlytrek Capsules, for Oral Use Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

Gtlive Glutathione 600mg Injection
Product IntroductionGtlive Injection is a medicine used in the treatment of liver disease. It also has a number of other health benefits and protects the body cells against damage caused by free radicals.
Gtlive Injection is administered as an injection by a healthcare professional. You should not self-administer this medicine at home.
Using of Gtlive Injection may cause few side effects such as redness, pain, and swelling at the site of injection. Please consult your doctor if these side effects persist for a longer duration.

Uses of Gtlive InjectionLiver disease

Benefits of Gtlive InjectionIn Liver diseaseGtlive Injection protects the liver from damage against harmful chemicals known as free radicals, thereby improving overall health of the liver. This helps the liver to perform its normal functions. It is given as an injection by a doctor or nurse and should not be self-administered. To make the medicine more effective and for general health benefits, stop smoking, maintain a healthy weight, and do not drink too much alcohol.

Side effects of Gtlive InjectionMost side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about themCommon side effects of GtliveInjection site reactions (pain, swelling, redness)

How to use Gtlive InjectionYour doctor or nurse will give you this medicine. Kindly do not self administer.

How Gtlive Injection worksGtlive Injection belongs to a class of medications called antioxidants. It works by protecting the liver from harmful chemical substances (free radicals), thus preventing liver damage.

Safety adviceAlcoholIt is not known whether it is safe to consume alcohol with Gtlive Injection. Please consult your doctor.
PregnancyInformation regarding the use of Gtlive Injection during pregnancy is not available. Please consult your doctor.
Breast feedingInformation regarding the use of Gtlive Injection during breastfeeding is not available. Please consult your doctor.
DrivingIt is not known whether Gtlive Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react. Please consult your doctor.
KidneyThere is limited data available on the use of Gtlive Injection in patients with kidney disease. Please consult your doctor.
LiverGtlive Injection is probably safe to use in patients with liver disease. Limited data suggest dose adjustment may not be needed.

Pertuzumab-Trastuzumab 1200mg/600mg Injection
Product IntoductionPhesgo 1200mg/600mg Solution for Injection is used to treat breast cancer. It works by killing the cancer cells and also prevents their further growth.
Pertuzumab/Trastuzumab 1200mg/600mg Solution for Injection is given as an injection into veins under the supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Hair loss, diarrhea, nausea, fatigue, and arthralgia are some common side effects of this medicine. This medicine may reduce the number of blood cells in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with the heart, liver, and kidney.
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. 

Use Of Pertuzumab/Trastuzumab Injection
Treatment of Breast cancer

Benefits Of Pertuzumab/Trastuzumab InjectionIn Treatment of Breast cancerBreast cancer occurs when abnormal cells grow uncontrollably in breast tissue, potentially spreading to other parts of the body. Pertuzumab/Trastuzumab 1200mg/600mg Solution for Injection helps slow the growth of cancer cells and reduces the risk of disease progression. It supports better control of the cancer, improves treatment outcomes, and helps patients maintain a higher quality of life during therapy.

Side Effects Of Pertuzumab/Trastuzumab InjectionMost side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about themCommon side effects of Pertuzumab/TrastuzumabHair lossNauseaDiarrheaJoint painFatigue


How To Use Pertuzumab/Trastuzumab Injection
Your doctor or nurse will guide you how to use this medicine.

How Pertuzumab/Trastuzumab Injection WorkPertuzumab/Trastuzumab 1200mg/600mg Solution for Injection is a combination of two anticancer medicines. Pertuzumab recognizes and attaches to a protein called human epidermal growth factor 2 (HER2). HER2 is abundantly present on the surface of some cancer cells where it stimulates their growth. When pertuzumab attaches to the HER2 cancer cells, it may slow or stop the cancer cells from growing, or may kill them. 
Safety AdviceAlcoholIt is not known whether it is safe to consume alcohol with Pertuzumab/Trastuzumab 1200mg/600mg Solution for Injection. Please consult your doctor.

PregnancyPertuzumab/Trastuzumab 1200mg/600mg Solution for Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. 
Breast feedingPertuzumab/Trastuzumab 1200mg/600mg Solution for Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
DrivingPertuzumab/Trastuzumab 1200mg/600mg Solution for Injection may cause side effects which could affect your ability to drive.
KidneyPertuzumab/Trastuzumab 1200mg/600mg Solution for Injection is safe to use in patients with kidney disease.
LiverThere is limited information available on the use of Pertuzumab/Trastuzumab 1200mg/600mg Solution for Injection in patients with liver disease. P